Daxant SA
2.0 FTEThe score of Daxant shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +4 % Total assets +23 % Headcount (avg FTE) -5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Daxant's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Daxant's financial analysis
- Solvency35.9%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Daxant
Daxant's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0426.468.616
- VAT number
- BE0426468616
- Peppol
- Registered · 0208:0426468616 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 26 Oct 1984
- Registered office
- 1020 Brussels
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 07 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Daxant (SA) has been based in Brussels since 1984, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 33,995 € and equity of 729,978 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 35.9%, above the median of its sector (32.3%).
Companies similar to Daxant
Companies in the same business, of comparable size and area, outside its group.
- Aboca Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €1.24m
- Les Pharmaciens Associés Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €4.80m
- Astel Medica Manufacture of pharmaceutical preparations Neupré · balance sheet €2.65m
- Grindeks Kalceks Belgium Wholesale of pharmaceutical and medical goods Aalst · balance sheet €2.14m
- Neuraxpharm Belgium Wholesale of pharmaceutical and medical goods Saint-Josse-ten-Noode · balance sheet €3.11m
- Laboratoires Lohmann & Rauscher Manufacture of pharmaceutical preparations Liège · balance sheet €4.03m
- Cordis Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €2.21m
- Maco - Pharma Benelux Manufacture of pharmaceutical preparations Mouscron · balance sheet €4.19m
Frequently asked questions about Daxant
What is the revenue of Daxant?
Daxant files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Daxant?
In Belgium, the VAT number is the company number prefixed with BE: BE0426468616 for Daxant, if the company is VAT-registered. Its company number (CBE) is 0426.468.616.
Where is the registered office of Daxant?
According to the CBE register, the registered office of Daxant is in 1020 Brussels.
What is the equity of Daxant?
At the close of the 2025 financial year, the equity of Daxant amounts to 729,978 €, a solvency of 35.9% of total assets.
How many people work at Daxant?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Daxant?
The register lists 4 active mandates at Daxant. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Daxant
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →